跳至主要内容
临床试验/JPRN-jRCTs021200009
JPRN-jRCTs021200009招募中2 期

A phase II study of CDDP+5-FU+Docetaxel and radiotherapy for postoperative recurrent esophageal cancer

Jingu Keiichi0 个研究点目标入组 35 人开始时间: 2020年6月18日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • 1)performed R0 resection for initial esophageal cancer
  • 2)clinically diagnosed as recurrence in local and/or regional lymph nodes
  • 3)Performance Status(ECOG)=0-2
  • 4)20-75 years old
  • 5)WBC>or= 3000/m3, PLT>or=100000/m3, Hb>or =10g/dl,
  • GOTCcr>or=60ml/min/body
  • 6)obtain written informed consent

排除标准

  • 1)with metastases in distant organ
  • 2)with irradiated history
  • 3)recurrent after endoscopic mucosal resection
  • 4)second primary cancer in residual esophagus
  • 5)with other active cancer
  • 6)with severe complication
  • 7)pregnant women, patients during lactation
  • 8)with active infection
  • 9) regularly use steroids
  • 10)with a pacemaker or defibrillator
  • 11)with complications that are considered to be difficult to complete this protocol

研究者

发起方
Jingu Keiichi

相似试验